Burkhart, D. L., Morel, K. L., Wadosky, K. M., Labbé, D. P., Galbo, P. M., Dalimov, Z., . . . Ellis, L. (2020). Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer. Cancer Prev Res (Phila).
Čikaški stil citiranjaBurkhart, Deborah L., Katherine L. Morel, Kristine M. Wadosky, David P. Labbé, Phillip M. Galbo, Zafardjan Dalimov, Bo Xu, Massimo Loda, i Leigh Ellis. "Evidence That EZH2 Deregulation Is an Actionable Therapeutic Target for Prevention of Prostate Cancer." Cancer Prev Res (Phila) 2020.
MLA način citiranjaBurkhart, Deborah L., et al. "Evidence That EZH2 Deregulation Is an Actionable Therapeutic Target for Prevention of Prostate Cancer." Cancer Prev Res (Phila) 2020.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.